Summary
In 20 diabetic inpatients with type IIb, III, IV and V hyperlipoproteinemia (HPL) the triglyceride fatty acid pattern (TFAP) of serum, adipose tissue and liver biopsy specimens before and after one year of clofibrate treatment has been determined by gas-liquid chromatography. Compared to previous results which revealed a correlation between fat droplet size and the TFAP in liver parenchyma cells, remarkable changes were observed after long-term therapy. Inadipose tissue, only linoleic acid increased significantly from 8.6 to 11.3%. Inserum, myristic and palmitic acid decreased, whereas linoleic, eicosatetraenoic (arachidonic) and eicosapentaenoic acid rose significantly. Inliver fat, palmitic acid decreased, whereas linoleic, eicosatrienoic, arachidonic and eicosapentaenoic acid significantly increased. After clofibrate therapy, the TFAP in diabetic subjects with HLP became similar to that of diabetics without HLP. The most pronounced changes were found in the liver, serum having an intermediate position between liver and adipose tissue. The pathophysiological relevance in view of possible relations to prostaglandins has been discussed.
Similar content being viewed by others
References
Adams L. L., Webb W. W., Fallon H. J.: Inhibition of hepatic triglyceride formation by clofibrate — J. clin. Invest.50, 2339, 1971.
Albutt E. C., Chance G. W.: Plasma and adipose tissue fatty acids of diabetic children on long-term corn oil diet — J. clin. Invest.48, 139, 1969.
Antonini F. M., Bucalossi A., Petruzzi E., Rimoni R.: Fatty acid composition of adipose tissue in normal, atherosclerotic and diabetic subjects — Atherosclerosis11, 279, 1970.
Azarnoff D. L., Tucker D. R., Barr G. A.: Studies with ethyl chlorophenoxyisobutyrate (clofibrate) — Metabolism14, 959, 1965.
Bagdade J. D., Porte D. Jr., Bierman E. L.: Diabetic lipemia: a form of acquired fat-induced lipemia — New Engl. J. Med.276, 427, 1967.
Bagdade J. D., Porte D. Jr., Bierman E. L.: Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects — Diabetes17, 127, 1968.
Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T.: Classification of hyperlipidemias and hyperlipoproteinemias — Bull. Wld. Hlth. Org.43, 891, 1970.
Berg G., Henning N., Troll U.: Fettsäuremuster der Fettleber — Verh. dtsch. Ges. inn. Med.71, 754, 1966.
Berg G., Troll U., Strunk U.: Das Fettsäuremuster des menschlichen Depotfettes — Klin. Wschr.46, 997, 1968.
Bergström S., Danielsson H., Klenberg D., Samuelsson B.: The enzymatic conversion of essential fatty acids into prostaglandins — J. biol. Chem.239, 4006, 1964.
Bernhard K., Petignat V., Schwed P.: Die Abhängigkeit der Fettsäurezusammensetzung des Leber- und Depotfettes von der Nahrung — Schweiz. med. Wschr.92, 477, 1962.
Bierman E. L., Hamlin J. T.: The effect of insulin and glucagon on the removal of C14-labeled particulate triglyceride in man — Metabolism12, 666, 1963.
Blomstrand R., Radner S.: Gas-chromatographic analysis of fatty acids in percutaneous liver biopsy specimens — Kungl. fysiogr. Sällsk. Lund Förh.32, 77, 1962.
Böhle E., Schrade W., Biegler R., Larbig D., Karytsiotis J.: Gaschromatographische Untersuchungen der Serumfettsäuren des Menschen — Klin. Wschr.39, 5, 1961.
Carlson L. A., Walldius G.: Association between a low adipose tissue content of polyunsaturated fatty acids and both glucose intolerance and hypertriglyceridemia in apparently healthy men — Acta med. scand.179, 295, 1975.
Cholesterol. Deutsches Arzneibuch, 7. Ausgabe — Akademie-Verlag, Berlin, 1972.
Daae L. N. W., Aas M.: Fatty acid activation and acyl transfer in rat liver during clofibrate feeding — Atherosclerosis17, 389, 1973.
Duncan Ch. H., Best M.M., Despopoulos A.: Inhibition of hepatic secretion of triglyceride by chlorophenoxyisobutyrate (CPIB) — Circulation30 (Suppl. III), 7, 1964.
Gellhorn A., Benjamin W.: Lipid biosynthesis in adipose tissue during aging and diabetes — Ann. N.Y. Acad. Sci.131, 344, 1965.
Gnauck G., Singer P., Thoelke H., Honigmann G., Schliack V.: Das Fettsäuremuster der Triglyceride im Serum von Patienten mit Hyperlipoproteinämie sowie Diabetes mellitus im Vergleich zu Stoffwechselgesunden — Dtsch. Gesundh.-Wes.30, 1510, 1975.
Gnauck G., Stolz P., Honigmann G., Singer P.: Die gaschromatographische Analyse der Lipid-Fettsäuren im Serum und Organgeweben — Z. med. Labortechn.14, 15, 1973.
Gnauck G., Thoelke H., Zegenhagen R., Singer P., Honigmann G.: Das Fettsäuremuster der Triglyceride und Cholesterolester im Serum von Stoffwechselgesunden — Dtsch. Gesundh.-Wes.29, 1406, 1974.
Gould R. G., Swyryd E. A., Coan B. J., Avoy D. R.: Effects of chlorophenoxyisobutyrate (CPIB) on liver composition and triglyceride synthesis in rats — J. atheroscler. Res.6, 555, 1966.
Haessler H. A., Crawford J. D.: Alterations in the fatty acid composition of depot fat associated with obesity — Ann. N.Y. Acad. Sci.131, 476, 1965.
Hamwi G. J., Garcia O., Kruger F. A., Gwinup G., Cornwell D. G.: Hyperlipidemia in uncontrolled diabetes — Metabolism11, 850, 1962.
Hanefeld M., Jaross W., Truebsbach A., Leonhardt W.: Untersuchungen zur Wirkung von Chlorfibrinsäure auf den Triglycerid- und Glykogengehalt der menschlichen Leber sowie blutspiegelbildende Metaboliten — Z. inn. Med.27, 655, 1972.
Heffernan A.G.A.: Fatty acid composition of adipose tissue in normal and abnormal subjects — Amer. J. clin. Nutr.15, 5, 1964.
Hirsch J., Farquhar J. W., Ahrens E. H., Peterson M. L., Stoffel W.: Studies of adipose tissue in man. A microtechnic for sampling and analyses — Amer. J. clin. Nutr.8, 499, 1960.
Homcy C. J., Margolis S.: Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes — Atherosclerosis19, 381, 1974.
Honigmann G., Gnauck G., Briedigkeit W., Singer P., Stolz P., Schliack V.: Das Fettsäuremuster der Triglyceride und Cholesterolester im Serum von stoffwechselgesunden Kindern — Dtsch. Gesundh.-Wes.30, 1465, 1975.
Insull W. Jr., Bartsch G. E.: Fatty acid composition on human adipose tissue related to age, sex and race — Amer. J. clin. Nutr.20, 13, 1967.
Knuechel F.: Das Verhalten der Serumlipide und — lipoproteine unter Verabreichung von Regelan (Aethyl-p-Chlorphenoxyisobutyrat) — Med. Welt (Stuttg.) II, 2530, 1964.
Krut L. H., Bronte-Stewart S.: The fatty acids of human depot fat — J. Lipid Res.5, 343, 1964.
Laurell S., Lundquist A.: Lipid composition of human liver biopsy specimens — Acta med. scand.189, 65, 1971.
Laurell S., Lundquist A.: Fatty acid patterns determined simultaneously in human adipose tissue, liver and plasma during starvation — Scand. J. clin. Lab. Invest.27, 29, 1971.
Menghini G.: One-second needle biopsy of the liver — Gastroenterology35, 190, 1958.
Mishkel M. A., Webb W. F.: The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzmalecene. Part 1. (The metabolism of free fatty acid-albumin complex by the isolated perfused liver) — Biochem. Pharmacol.16, 897, 1967.
Reunanen A., Miettinen T. A., Nikkilä E.A.: Quantitative lipid analysis of human liver needle biopsy specimens — Acta med. scand.186, 149, 1969.
Schön H., Krause U., Elster K.: Das Fettsäuremuster der menschlichen Leber im Zustand der Verfettung — Klin. Wschr.41, 743, 1963.
Schrade W., Böhle E., Biegler R.: Über Fortschritte der Fettstoffwechselforschung und ihre klinische Bedeutung — Dtsch. med. Wschr.86, 781, 1961.
Scott R. F., Lee K. T., Kim D. N., Morrison E. S., Goodale F.: Lack of correlation between fatty acid patterns in adipose tissue and amount of coronary arteriosclerosis — Amer. J. clin. Nutr.14, 280, 1964.
Singer P., Gnauck G.: Das Fettsäurespektrum der Triglyceride im Leber- und subcutanen Fettgewebe bei Diabetikern mit und ohne Leberverfettung — In:Haller H., Hanefeld M., Jaross W. (Eds): Symposium über Lipidstoffwechselerkrankungen. VEB Berlin — Chemie, Dresden, 1973; p. 442.
Singer P., Gnauck G., Honigmann G.: The fatty acid composition of the triglycerides in liver and subcutaneous fat in diabetics in dependence on liver fatty degeneration — Acta med. pol.15, 27, 1974.
Singer P., Gnauck G., Honigmann G., Stolz P., Schliack V., Kettler L.-H., Buntrock P., Thoelke H.: The fatty acid pattern of adipose tissue and liver triglycerides according to fat droplet size in liver parenchyma cells of diabetic subjects — Diabetologia10, 455, 1974.
Singer P., Gnauck G., Honigmann G., Stolz P., Schliack V., Thoelke H., Kettler L.-H., Buntrock P.: Fatty acid composition of liver triglycerides in various stages of fat deposition in the parenchyma — Acta diabet. lat.11, 32, 1974.
Singer P., Gnauck G., Thoelke H., Honigmann G., Buntrock P., Kettler L.-H.: Zum Verhalten des Fettsäuremusters der Triglyceride im Leberparenchym und Depotfett bei Diabetikern in Abhängigkeit von der Leberverfettung — Dtsch. Z. Verdau.-u. Stoffwechselkr.34, 27, 1974.
Stolz P., Rost G., Honigmann G.: Eine einfache Mikromethode zur Bestimmung der Triglyceride im Serum — Z. med. Labortechn.9, 215, 1968.
Sweeney M. J., Etteldorf J. N., Throop L. J., Timma D. L., Wrenn E. L.: Diet and fatty acid distribution in subcutaneous fat and in the cholesterol-triglyceride fraction of serum of young infants — J. clin. Invest.42, 1, 1963.
Takahashi Y., Tanaka K.: Gas-chromatographic analyses of the fatty acid composition of human fatty liver — J. Biochem.48, 413, 1961.
van Dorp D. A., Beerthuis R. K., Nugteren D. H., Vonkeman H.: The biosynthesis of prostaglandins — Biochim. biophys. Acta (Amst.)90, 204, 1964.
Wagner H., Seelig E., Bernhard K.: Studien zur Biochemie der essentiellen Fettsäuren. V. Die Verweilzeit der Linolsäure im Organismus der Ratte — Hoppe-Seylers Z. physiol. Chem.313, 235, 1958.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singer, P., Gnauck, G., Honigmann, G. et al. The fatty acid pattern of triglycerides in liver, adipose tissue and serum of diabetics with hyperlipoproteinemia before and during clofibrate treatment. Acta diabet. lat 15, 40–52 (1978). https://doi.org/10.1007/BF02581006
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581006